Table 4.
Group | n | Immunohistochemistry | Western-blot | ||||
---|---|---|---|---|---|---|---|
|
|
||||||
HDAC2 | PI3K | p-AKT | HDAC2 | PI3K | p-AKT | ||
Healthy control group | 10 | 90.05±2.38 | 21.22±2.19 | 23.76±1.26 | 0.636±0.032 | 0.193±0.013 | 0.225±0.085 |
COPD model group | 10 | 18.06±1.27* | 99.15±6.85* | 104.43±5.69* | 0.115±0.014* | 0.745±0.029* | 0.786±0.067* |
Budesonide group | 10 | 32.49±5.49‡ | 76.43±3.32‡ | 87.64±4.23‡ | 0.201±0.098** | 0.632±0.035** | 0.699±0.049** |
Erythromycin group | 10 | 53.33±3.24†,§ | 57.72±4.51†,§ | 64.38±3.79†,§ | 0.479±0.046†,§ | 0.458±0.038†,§ | 0.583±0.025†,§ |
Erythromycin + budesonide group | 10 | 67.02±2.28†,§ | 44.83±2.67†,§ | 57.21±5.65†,§ | 0.501±0.037†,§ | 0.332±0.043†,§ | 0.417±0.087†,§ |
Compared with healthy control group, P<0.05;
Compared with COPD model group, P<0.05;
Compared with budesonide group, P<0.05;
Compared with COPD model group, P=0.145, 0.203, 0.178;
Compared with COPD model group, P=0.423, 0.706, 0.693.